What Are the Limitations of BioCarta in Cancer Research?
While BioCarta is a valuable resource, it has limitations. The pathways are curated based on existing knowledge, which may not encompass all molecular interactions relevant to cancer. Additionally, the static nature of these maps doesn’t account for the dynamic changes in pathways that occur in different cancer stages or in response to treatment.
